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ABSTRACT
The RecG helicase of Escherichia coli unwinds both
Holliday junction (HJ) and replication fork DNA sub-
strates. Our lab previously identified and character-
ized peptides (WRWYCR and KWWCRW) that block
the activity of RecG on these substrates. We deter-
mined that the peptides bind HJ DNA and prevent
the binding of RecG. Herein, we present further evi-
dence that the peptides are competitive inhibitors of
RecG binding to its substrates. We have generated
structural models of interactions between WRWYCR
and a junction substrate. Using the fluorescent
probe 2-aminopurine, we show that inhibitors inter-
act with highest affinity with HJs (Kd=14nM) and
~4- to 9-fold more weakly with replication fork sub-
strates. The fluorescence assay results agree with
the structural model, and predict the molecular
basis for interactions between HJ-trapping peptides
and branched DNA molecules. Specifically, aromatic
amino acids in the peptides stack with bases at the
center of the DNA substrates. These interactions
are stabilized by hydrogen bonds to the DNA and
by intrapeptide interactions. These peptides inhibit
several proteins involved in DNA repair in addition to
RecG, have been useful as tools to dissect recom-
bination, and possess antibiotic activity. Greater
understanding of the peptides’ mechanism of
action will further increase their utility.
INTRODUCTION
Holliday junctions (HJ) and other branched DNA
intermediates are processed during recombination and
repair in all organisms by a variety of ubiquitous helicase
enzymes (1–5). In general, helicases translocate along
DNA in an ATP-dependent manner in order to separate
DNA strands or to drive branch migration (6,7). Unlike
hexameric helicases such as DnaB and RuvB (4,8), the
monomeric RecG helicase of Escherichia coli catalyzes
the interconversion of replication forks and HJ (9,10).
This interconversion is likely accomplished by the simul-
taneous unwinding of the leading and lagging strands of a
replication fork, which then reanneal with each other to
form a HJ (11,12). RecG was ﬁrst characterized for its role
in promoting DNA recombination and repair in conjunc-
tion with the RuvABC resolvase complex (13,14). A role
for RecG at the interface between replication, recombina-
tion and repair (15) is consistent with the ﬁnding that
RecG binds to both HJ and replication forks in vitro
with high aﬃnity (10,16,17). RecG has very low activity
on partially duplex ‘ﬂayed’ DNA molecules, and binds to
these substrates with as much as 100-fold lower aﬃnity in
comparison to the HJ (17).
We previously identiﬁed hexapeptides that inhibit
several site-speciﬁc tyrosine recombination enzymes and
lead to the accumulation of HJ intermediates both
in vitro and in vivo (18–25; Boldt,J. and Segall,A., unpub-
lished data). The enzymes inhibited include bacteriophage
lambda Integrase (Int), the Cre recombinase of bacte-
riophage P1, the XerCD site-speciﬁc recombinase of
E. coli, and the Flp recombinase of the 2mm plasmid in
Saccharomyces cerevisiae (20,24; Conway,A. and Rice,P.,
unpublished data). Peptides WRWYCR and KWWCRW
are the most potent inhibitors and are capable of trapping
virtually all HJ formed during Int-mediated recombina-
tion with a half-maximal inhibitory concentration (IC50)
of 5–20nM (19,20). The active form of each peptide is a
dimer linked through a disulﬁde bridge (20,22), and thus
we denote these peptides herein as (WRWYCR)2 and
(KWWCRW)2. These peptides also inhibit unwinding
of branched DNA substrates by RecG and HJ resolution
by the RuvABC complex (22), and inhibit the D-loop
unwinding activity of the human RAD54 protein (26).
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for HJ DNA: peptides (WRWYCR)2 and (KWWCRW)2
bind speciﬁcally to free HJ DNA (22). The relatively
weaker inhibitory peptide WKHYNY traps HJ during
Int- and Cre-mediated recombination (IC50 0.2–20mM,
depending on the recombination pathway), and inhibits
RecG activity weakly (IC50 20–100mM) (18,20,21,23;
Kepple,K. and Segall,A., unpublished data). While
WKHYNY does not contain a cysteine and thus is
unlikely to form a stable dimer in solution, crystal struc-
ture data indicate that this peptide also associates with
Cre–HJ complexes as a dimer (23).
There are many intriguing parallels between peptide
(WRWYCR)2 and the RecG helicase. The speciﬁcity of
RecG for branched DNA molecules resides in a ‘wedge’
domain linked to the helicase domains (12,27). In the crys-
tal structure of Thermotogota maritima RecG bound to
a replication fork with only a lagging strand, Phe204
and Tyr208 contact the central bases of the fork in a
manner that mimics base stacking (12). RecG activity
decreases signiﬁcantly in vivo and in vitro when the equiva-
lent or near-equivalent residues in E. coli RecG were
mutated (27), and aromatic residues are present in the
analogous positions in RecG throughout the bacterial
domain (Patel,N. et al., in preparation). The most
potent peptide inhibitors all contain 2–3 aromatic resi-
dues, particularly Tyr and Trp (19,20) with a similar spa-
cing to that between Phe204 and Tyr208 of T. maritima
RecG. Like RecG, the peptides prefer square-planar
HJ structures, and binding is strongly inhibited by
Mg
2+ or spermidine, that fold the junction arms into a
‘stacked-X’ conformation (17,22,28–30). Finally, when
peptide and RecG are added together to HJ, we observed
mostly peptide–HJ complexes, indicating that the peptide
prevents RecG from binding to its substrate (22). Based
upon these parallels and supporting data, we reasoned
that the peptides may bind in the same manner as the
RecG wedge domain to the central region of the junction
and may compete with RecG for the HJ substrate by
making similar contacts (22). Our hypothesis is supported
by the observation that the RecG wedge domain by itself
binds HJ with high aﬃnity (Kd 1.6nM), although addi-
tional contacts not found in the wedge domain are
required for binding to replication forks (27).
Inhibition of RecG helicase activity on replication
forks would be easily explained if the peptides bound to
these structures and competed with the binding of the
helicase. However, we were unable to detect binding of
(WRWYCR)2 or (KWWCRW)2 to replication fork sub-
strates using band shift assays (K. Kepple, Ph.D. Thesis,
2006). This could be either because the peptide–substrate
complexes are too unstable during gel electrophoresis,
or because the peptides interact with RecG in solution
and prevent its interactions with the DNA substrate.
In order to test whether complexes form between the pep-
tide and replication forks we have used the ﬂuorescent
adenine analog 2-aminopurine (2-AP) in a ﬂuorescence
quenching assay.
We also investigated the similarity of binding interac-
tions with DNA substrates between the peptides and
RecG in order to get more insights into the interactions
of the peptides with DNA substrates. One of the peptides
we identiﬁed, WKHYNY, was co-crystallized in a com-
plex of Cre–protein with HJ; however, the resolution of
the WKHYNY peptide-dependent electron density was
too low to determine any detailed interactions (23). We,
now present further evidence that the peptides directly
compete with RecG for HJ substrates. We have generated
structural models for peptide interactions with branched
DNA and used 2-AP to test binding and validate the
models based on its previous wide utility as a probe for
protein–DNA interactions, including protein–HJ binding
interactions (23,31,32). We show that (WRWYCR)2 and
(KWWCRW)2 quench the ﬂuorescence of 2-AP bases
placed in the center of both HJ and replication forks.
The ﬂuorescence data was used to calculate the aﬃnity
of (WRWYCR)2 to the various substrates. The relatively
weak inhibitor WKHYNY does not bind protein-free
junctions. The results of the modeling experiments
between (WRWYCR)2 and a HJ are conﬁrmed by the
2-AP ﬂuorescence results and provide a nice framework
for our hypothesis.
MATERIALS AND METHODS
Oligonucleotide synthesis andpurification
Oligonucleotides 1–4 (Supplementary Table 1) were
purchased from Integrated DNA Technologies (San
Diego, CA, USA) and were puriﬁed on 12% polyacryla-
mide gels containing 7M urea. Oligonucleotides 5–18 were
synthesized on an Applied Biosystems Model 392 DNA/
RNA synthesizer using standard phosphoramidite chem-
istry. The oligonucleotides were puriﬁed by reverse-phase
HPLC (Gemini C18, 10mm, 110A ˚ , 250 21.2mm
column, Phenomenex) using a 5–60% acetonitrile linear
gradient in 100mM TEAA buﬀer, pH 7.0. The trityl
group was subsequently removed with 80% acetic acid
and ethanol precipitated. The size and purity of oligonu-
cleotides were assessed using polyacrylamide gel electro-
phoresis followed by ethidium bromide staining.
Nucleotides and reagents for DNA synthesis were pur-
chased from Glen Research (Sterling, VA, USA).
Peptides, proteins andassembly ofbranched DNA substrates
Peptides were synthesized with a C-terminal amide group
and puriﬁed to >95% at Sigma-Genosys Inc. (St. Louis,
MO, USA) and dissolved in 100% DMSO. Dr Peter
McGlynn (University of Aberdeen, Scotland) generously
provided the RecG protein. Synthetic oligonucleotides 1–4
(Supplementary Table 1) were used to make HJ DNA for
RecG and peptide band shift assays. Oligonucleotide 1
was labeled at the 50 end using [g-
32P]ATP and T4 poly-
nucleotide kinase (New England Biolabs, Ipswich, MA,
USA). Combinations of oligonucleotides 5–15 were used
to assemble HJ substrates for 2-AP assays. Combinations
of oligonucleotides 5, 6 and 11–18 were used to assemble
replication fork substrates. The appropriate mixtures of
oligonucleotides were combined in 40ml 10mM Tris–
HCl (pH 7.8)/1mM EDTA/0.2M NaCl buﬀer and
boiled for 5min followed by slow cooling at room tem-
perature. Substrates were puriﬁed by nondenaturing
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by band excision and elution into a small volume of
TE/0.5M NaCl. The DNA was quantiﬁed by
spectrophotometry.
RecG/peptide band shiftand dissociation assays
Gel mobility shift assays were performed in a 20ml volume
and contained 20mM Tris–HCl (pH 8.0), 0.1mM EDTA,
55mM NaCl, 0.01% DMSO, 50ng salmon sperm DNA,
0.1mg/ml BSA, 6% (v/v) glycerol and 2nM
32P-labeled
HJ substrate. A ﬁnal concentration of 0.025, 0.1 or 0.5mM
(WRWYCR)2 was added to the reaction buﬀer and this
was immediately followed by addition of the indicated
amounts of RecG. Reactions were incubated for 30min
on ice and loaded onto a 5% native polyacrylamide gel.
Electrophoresis was performed in 0.5X TBE buﬀer at 48C.
Dissociationexperimentsbasedonmethodsdetailedpre-
viously (17,30) were performed with 0.015mM
(WRWYCR)2 in buﬀer that contained 20mM Tris–HCl
(pH 8.0), 55mM NaCl, 0.1mM EDTA, 0.01% DMSO,
0.1mg/ml BSA, 6% (v/v) glycerol and 1nM
32P-labeled
HJ substrate. Reactions were assembled on ice in a total
volume of 229ml and allowed to equilibrate for 15min.
A2 0 ml aliquot was then loaded onto a running 8%
native polyacrylamide gel in 0.5X TBE at 48C. Unlabeled
HJ competitor (11ml, giving a ﬁnal concentration of
0.2mM) was added to the remaining reaction mix and
20ml aliquots were immediately loaded on the gel at
increasing time points after stirring. A reaction containing
competitor HJ DNA prior to addition of peptide was also
included to verify that suﬃcient competitor was present to
act as a sink for unbound peptide. This experiment was
repeated using 0.02mM RecG in order to compare the dis-
sociationratesofpeptideandRecGundertheseconditions.
For the dissociation experiment in Figure 2D, a 191ml
reaction mix was assembled containing 0.02mM RecG
and was preincubated for 15min on ice. A 20ml aliquot
of this reaction mixture was then loaded on a running 8%
native polyacrylamide gel in 0.5X TBE at 48C. Unlabeled
HJ competitor (9ml, ﬁnal concentration of 0.2mM) was
added to the reaction mix and 20ml aliquots were loaded
on the gel at increasing time points. A second reaction
mixture was set up in parallel under identical conditions,
except that (WRWYCR)2 was added (0.1mM ﬁnal concen-
tration) in place of unlabeled HJ competitor. Reactions
containing competitor HJ DNA or peptide prior to addi-
tion of RecG were also run on the gel as controls. All gels
containing
32P-labeled DNA were dried and exposed to
a Molecular Dynamics PhosphorImager screen, then
visualized with ImageQuant software from Molecular
Dynamics.
(WRWYCR)2/HJ modeling
The DNA from the crystal structure of the Cre/loxP HJ
(33, PDB: 3CRX; NDB: PD0104) was used for modeling
of the (WRWYCR)2/HJ complex. The loxP HJ is com-
posed of four DNA strands denoted as C, D, E and F. The
WRWYCR monomer (from Supplementary Figure 1C)
was dimerized using the Biopolymer module of InsightII
(Accelrys, San Diego, CA, USA) (34,35). The amino acid
residues of the ﬁrst monomer are labeled with an ‘a’, while
those of the second monomer are labeled with a ‘b’ (e.g.
W1a versus W1b). A series of manual rotation and mini-
mization steps were carried out to obtain the trans-dimer
structure of peptide WRWYCR (Figure 4A), which was
expected to ﬁt better with the 2-fold symmetry of the HJ
substrate. The missing hydrogen atoms were added with
the MSI/Biopolymer module (34,35). Energy minimiza-
tion was performed using the InsightII/Discover module
(34–38) using a consistent valance force ﬁeld (CVFF,
Biosym Inc.) (39–43). This trans-peptide dimer was manu-
ally docked into the loxP HJ. Several diﬀerent conﬁgura-
tions were tested by rotating the molecule in diﬀerent
orientations. Amino acids W1a, Y4a, W1b and W3b
were manually rotated to achieve the best initial ﬁt at
the junction center (Figure 3B). This starting structure
was further reﬁned using three diﬀerent energy minimiza-
tion steps. In the ﬁrst step, the preliminary model shown in
Figure 3B was subjected to 1500 iterations of conjugate
gradient energy minimization, while keeping all DNA
chains and the amino acids W1a, W1b and W3b con-
strained. The resulting model is shown in Figure 3C. A
second round of minimization (1000 iterations) was per-
formed in order to optimize potential interactions between
amino acids W1a, W1b, W3b and Y4a and the corre-
sponding nucleotides with which they interact (D: A18,
E: A18, C: A19, C: T18); the remaining structure was
kept constrained, and the resulting model is shown in
Figure 4D. This was followed by an additional 2000 itera-
tions in which the HJ was constrained except for the C:
T18 and C: A19 bases. Subsequently, amino acids W1a
and W1b were constrained but the remaining peptide
dimer structure was released for this minimization. The
ﬁnal (WRWYCR)2/HJ models are presented in space-ﬁll-
ing views in Figure 3E, after a 908 clockwise rotation from
3D and F, after 1808 rotation along the Y-axis from 3E.
Fluorescence measurements and dataprocessing
Fluorescence spectra were recorded using a Photon
Technology International Model QM-4/2005 scanning
spectroﬂuorometer (Birmingham, NJ, USA). Samples
(125ml) contained 0.2mM substrate, 20mM Tris–HCl
(pH 7.8), 100mM NaCl, 1mM EDTA, 0.032% DMSO
and the speciﬁed concentration of peptide. Reactions
were allowed to equilibrate for a least 10min before trans-
ferring to a quartz cuvette. Emission spectra between 330
and 430nm were recorded at 1nm intervals using an exci-
tation wavelength of 315nm to minimize interference by
tryptophan residues in the peptides. Monochromator
bandpasses were ﬁxed at 4nm for excitation and 8nm for
emissioninallmeasurements.Experimentswereperformed
at 248C and the spectra obtained were corrected for lamp
ﬂuctuations. When necessary, spectra were also corrected
for instrumental variations caused by sample manipula-
tion. DTT was present at 10mM where applicable.
Peptide titrations (2ml starting volume) contained
0.1 or 0.2mM substrate as indicated, 20mM Tris–HCl
(pH 7.8), 25mM NaCl, 1mM EDTA and 1.6% DMSO.
Peptide was diluted in the same buﬀer and added directly
to the sample cuvette with reaction mixture at 248C.
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with gentle stirring with a magnetic stir bar before tak-
ing measurements. Corrections to ﬂuorescence intensity
resulting from small dilutions were made after measure-
ments were complete. All emission spectra and ﬂuores-
cence intensity measurements were corrected for
background emission by subtracting spectra in which the
2-AP in each substrate was replaced with adenine. The
ﬂuorescence values at each peptide concentration between
365 and 375nm were averaged. The data were processed
and analyzed using FeliX32 Fluorescence Analysis Soft-
ware (PTI). The corrected ﬂuorescence spectra (Fcorr)
were smoothed for clarity, ﬁtted to the equation below
and re-plotted using MATLAB (MATLAB2007a,
fminsearch).
Model fitting offluorescence datato obtain the
Kdof peptidefor eachsubstrate
The model for the ﬁts was based on expressing the
fraction bound in terms of the total ligand and receptor
present, and the equilibrium constant. The data was ﬁt to
the equation (44):
Fc ¼
Lb
Rt
¼
Lt þ Rt þ Kd  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Lt þ Rt þ Kd ðÞ
2 4Lt Rt
q
2Rt
where Lb is the concentration of bound ligand; Lt,
concentration of total ligand added to the solution; Rt,
concentration of receptor molecules; and Kd, dissociation
constant for the binding site.
The ﬁtting was accomplished by adjusting the dissocia-
tion constant Kd to measured values of total peptide
(ligand) added, Lt, and spectroscopically measured values
of the fraction complexed, Fc, in a reaction with a prepared
concentration of substrate (receptor) molecules, Rt. The
values of Kd were adjusted to minimize the sum squared
error between the measured Fc and the value predicted by
this equation for the concentration of ligand added. The
measurements were performed with unaged peptide solu-
tions which had a monomer concentration approximately
equal to the dimer concentration, as seen using HPLC.
To correct for this, the Lt value in the equation was
taken to be 0.67X of the total peptide monomers added.
Minimizing the sum squared error is equivalent to
maximizing the fraction of explained variation, R
2. Two
(in some cases, three) independent dilution series were
measured to obtain the data for each of the curves. The
ﬁts were made to the pooled measurements for all the
dilution series for that substrate. The error bars shown
were shifted for readability. Our methods for estimating
the error bars and for ﬁnding conﬁdence intervals for our
Kd values are described in the Supplementary Data.
RESULTS
(WRWYCR)2inhibits RecGby competing for
theHJ substrate
Previously, gel mobility shift and footprinting assays
demonstrated that RecG cannot bind to a HJ substrate
when peptide is bound (22). We performed a competition
experiment between RecG and peptide (WRWYCR)2
to expand this data (Figure 1). The formation of a
peptide/HJ complex typically results in a very slight
upward band shift (Figure 1A, compare lanes 1 and 2
or Figure 2A lane 2 versus 3). Peptide concentrations
are given for the dimeric form throughout this work.
Binding of 0.02mM RecG to the HJ substrate is strongly
inhibited by 0.025mM peptide dimer, and binding is
almost completely inhibited in the presence of 0.1mM pep-
tide. However, when more RecG is present in the reaction,
more peptide is required to see inhibition: at 0.2mM
RecG there is only weak inhibition by 0.025mM peptide
(Figure 1A, lane 14). This data illustrates that inhibition
of RecG by (WRWYCR)2 occurs by a competitive
mechanism.
Peptide (WRWYCR)2 has a dissociation constant (Kd)
of 12.5nM by band shift assay, which is very similar to
what we observe for RecG in our gel mobility shift assays
in the presence of 50ng nonspeciﬁc double-stranded DNA
(dsDNA) (data not shown). We also examined the relative
stabilities of peptide/HJ and RecG/HJ interactions by
testing the dissociation of either peptide or RecG from
HJ substrates (Figure 2). Peptide (WRWYCR)2 was pre-
incubated in reactions containing
32P-labeled HJ DNA,
Figure 1. (WRWYCR)2 competes with RecG for the HJ substrate. Pep-
tide concentrations are represented in dimeric form since (WRWYCR)2
is active as a dimer (20,22). (A) The indicated amounts of RecG and
(WRWYCR)2 (0.025, 0.1 and 0.5mM) were added to reaction buﬀer
with 2nM
32P-labeled synthetic junction DNA. Reactions were incu-
bated for 30min at 48C, and then run on a 5% native polyacrylamide
gel at 48C. The slow-migrating band consists of two RecG monomers
bound to one HJ substrate (17). (B) Quantiﬁcation of the data in part
(A). The % DNA bound includes both one and two RecG monomers
bound to the HJ substrate.
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and reactions were loaded on a polyacrylamide gel at
increasing time points (Figure 2A). For comparison, the
experiment was repeated with RecG under the same con-
ditions (Figure 2B). More than an hour is required for half
of the peptide bound to the labeled junction to dissociate
and bind to the excess unlabeled junction (Figure 2C).
In contrast, half of the RecG bound to the labeled junc-
tion dissociates in 25min. We conclude that (WRWYCR)2
dissociates from HJ about 2X slower than the RecG
protein. Inhibition of RecG–DNA complexes by peptide
dimer occurs whether the peptide is added to DNA
10min before or after RecG (data not shown; Saha,R.
and Segall,A. unpublished data).
Thus, when RecG dissociates from the junction, peptide
(WRWYCR)2 can take its place in a ‘passive’ competition.
Another possibility we considered is that the peptide
may be able to actively displace RecG from the HJ. This
might be possible if the peptide makes additional or more
favorable interactions with the junction that are not
made by RecG. As described above, RecG speciﬁcally
interacts with DNA via stacking of two aromatic residues
with branch point bases (12,27); however, other central HJ
bases might be targeted by the peptide inhibitor. This was
Figure 2. Dissociation rate of the (WRWYCR)2/HJ complex. (A) 0.015mM (WRWYCR)2 was added to reaction buﬀer with 1nM
32P-labeled
synthetic junction DNA and incubated for 15min at 48C. A ﬁnal concentration of 0.2mM unlabeled HJ DNA competitor was added and reactions
(20ml) were loaded at increasing time points on a running 8% native polyacrylamide gel at 48C. DMSO is present in all reactions, in both panels A
and B. The ﬁrst three lanes are controls showing labeled HJ substrate alone, substrate preincubated with 0.2mM unlabeled HJ competitor before
addition of 0.015mM (WRWYCR)2, and substrate preincubated with (WRWYCR)2 only. (B) Stability of RecG on HJ under identical conditions.
The ﬁrst three lanes are controls showing labeled HJ substrate alone, substrate preincubated with 0.2mM unlabeled HJ competitor before addition of
0.02mM RecG and substrate preincubated with RecG only. (C) Quantiﬁcation of the data in part A and B. (D) Experiment demonstrating that
(WRWYCR)2 can displace RecG from HJ DNA. In lanes 5–12, 0.02mM RecG was preincubated with 1nM labeled synthetic junction DNA and
then a ﬁnal concentration of 0.2mM unlabeled HJ DNA competitor was added before loading the reactions on a running polyacrylamide gel as in
part B. In parallel, 0.1mM (WRWYCR)2 was used as the competitor for a second set of reactions instead of unlabeled HJ DNA (lanes 13–20).
(WRWYCR)2 immediately abolishes the HJ/RecG complex but not the HJ/RecGx2 complex. Lanes 1–4 are controls showing HJ substrate alone,
substrate preincubated with 0.2mM unlabeled HJ DNA competitor before addition of 0.02mM RecG, substrate preincubated with 0.1mM
(WRWYCR)2 before addition of 0.02mM RecG, and substrate preincubated with 0.02mM RecG only.
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challenge with both unlabeled HJ competitor and an
inhibitory concentration of peptide (Figure 2D). Half of
RecG bound to the labeled junction dissociated between
15 and 30min after addition of excess unlabeled HJ com-
petitor, as before (Figure 2D, lanes 5–12). In contrast,
addition of peptide almost immediately (from the time
required to add peptide, mix and the load gel) eliminated
the RecG/HJ complex (Figure 2D, lanes 13–20). Both sets
of reactions were done in parallel under identical condi-
tions. Interestingly, the slow-migrating band previously
identiﬁed as two RecG monomers bound to one HJ sub-
strate (17) takes far longer to disappear, indicating that
RecG interferes with peptide binding when more than one
RecG monomer is bound. In the model of the RecG/HJ
complex based on the RecG crystal structure, one RecG
monomer occupies one ‘face’ of the HJ (12). The second
RecG monomer could conceivably occupy the other side
of the junction, blocking access of the peptide to the junc-
tion center. Alternatively, the second monomer could
change the conformation of the junction in a way that
makes it a worse target for the peptide.
Modelingof (WRWYCR)2boundto aHJ
Based on the results described above indicating that the
peptide is a competitive inhibitor of RecG, and based on
the co-crystal structure of RecG interacting with a replica-
tion fork (12), we hypothesized that the peptide interacts
with branched DNA substrates very similarly to RecG.
We performed molecular modeling experiments in order
to further test the plausibility of this proposal, and present
a model of the interactions between the peptide and
a replication fork in Supplementary Figure 1. To model
peptide interactions with HJ DNA, we ﬁrst dimerized the
peptide and then docked it to a junction. For the DNA
substrate, we used the HJ coordinates from the crystal
structure of the Cre/loxP HJ complex (33), since
(WRWYCR)2 inhibits Cre/lox recombination with an
IC50 of 0.2mM by trapping HJ intermediates in the reac-
tion (20). The WRWYCR monomer was dimerized
through a disulﬁde bridge and energy-minimized to yield
a trans-dimer peptide, based on the hypothesis that a
trans-dimer will dock better into the 2-fold symmetric
structure of the HJ (Figure 3A). This dimer peptide was
manually docked into the Cre/loxPHJ–peptide co-crystal.
After manual rotation of amino acids W1a, Y4a, W1b
and W3b (Figure 3B; a and b refer to the diﬀerent pep-
tide monomers within the dimer), the structure was
run through three diﬀerent energy minimization steps
(Materials and methods section), whose respective results
are shown in Figure 3C–F.
In the ﬁrst minimization, the DNA chains and amino
acids W1a, W1b and W3b were kept constrained. This
minimization process was carried out to relax the peptide
at the center of the junction (Figure 3C; in this panel, the
junction has been rotated 1808 around the vertical axis
with respect to its orientation in Figure 3B). Four possible
stacking interactions between W1a and D: A18, W1b and
E: A18, W3b and C: A19 and between Y4a and C: T18
were observed at the four corners of the HJ. In the second
round of minimization amino acids W1a, W1b, W3b
and Y4a and their corresponding interacting DNA bases
were allowed to move but all other atoms were con-
strained. While the second minimization did not aﬀect
the two stacking interactions on the left side of the junc-
tion (between W1a and D: A18 and between W1b and
E: A18), the two possible stacking interactions between
W3b and C: A19at bottom right and between Y4a and
C: T18at the top right corner were lost (Figure 3D). This
may have been due either to gain of stability from addi-
tional interactions or to steric clashes at these two corners
of HJ. After moving away from the C: T18 base, the Y4a
residue at the top right corner established a T-shaped
aromatic–aromatic interaction (45) with the W1a residue.
The base C: A19 moved far from W3b, possibly because
of steric clashes either due to the short distance (<3A ˚ )
between them or with other amino acids (R6b is <3A ˚
away from C: A19; Figure 3D).
The ﬁnal (WRWYCR)2/HJ model after the third mini-
mization is shown in space-ﬁlling form (front view in
Figure 3E and rear view in 3F). The change in view
from Figure 3D to 3E was obtained by a  908 clockwise
rotation. The change in view from Figure 3E to 3F was
obtained by 1808 rotation along the Y-axis. In this minimi-
zation, all residues except the C: T18 and C: A19 nucleo-
tides and the W1a and W1b amino acids were kept
constrained. Most of the amino acids from the peptide
were released here to gain better contacts between the
peptide and DNA. After this third minimization, the
W3b residue prefers stacking with the F: T18 base rather
than with C: A19 in the bottom right corner (Figure 3D).
We also found that the W3a may substitute for Y4a pre-
viously interacting with the C: T18 base at the top right
corner. This competition between Y4a and W3a indicates
that W3a is an important residue for making stacking
interactions. This redundancy is also seen when testing
single alanine-substituted peptides both in vitro in bind-
ing assays and in vivo for antimicrobial activity, where the
alanine substitution at the third position (W3A) reduces
the potency of the peptide more severely than the substi-
tution at the fourth position (Y4A) (A. Flores, N. Patel
and A. Segall, in preparation). The predicted aromatic
interactions between W1a and D: A18, W1b and E: A18
and W3b and F: T18 are all clearly visible in Figure 3F.
The intra-peptide T-shaped aromatic interactions (45,46)
between Y4a and W1a, present even in the initial model,
are retained after the third minimization (clearly visible
in Figure 3D and E). In the ﬁnal model we also found a
p-cationic intrapeptide interaction (47,48) between the
R6a and Y4a (purple) (Supplementary Figure 2). An addi-
tional 3-member stacking interaction between E: T18,
W1b (pink) and Y4b (red) near the junction center is
also evident. These intrapeptide p-stacking and p-cationic
interactions may further stabilize binding between the
peptide and the DNA, and reveal why the active peptide
form is a dimer. We started with two aromatic stacking
interactions between a peptide monomer and a replication
fork (summarized in Table 1); the dimer had a third aro-
matic stacking interaction between the peptide and the
DNA via the second peptide, and three new H-bonds,
one between R6 and a backbone phosphate, and two
5324 Nucleic Acids Research, 2008, Vol. 36, No. 16Figure 3. Modeling of (WRWYCR)2 on HJ DNA. Arginine residues (R2a, R6a, R2b and R6b) are green and the two cysteine residues are yellow. The
four tryptophan residues are: W1a (magenta), W1b(pink), W3a (turquoise) and W3b (blue), and the two tyrosine residues are Y4a (purple) and Y4b (red).
(A) The trans-conformation of (WRWYCR)2.( B) Preliminary structure of (WRWYCR)2 docked into the Cre-loxP HJ after manual rotation of amino
acids W1a, Y4a, W1b and W3b. The resulting four potential stacking interactions between these amino acids and the four corners of the HJ (bases
highlighted in orange) are shown. (C) Interactions between (WRWYCR)2 and HJ after the ﬁrst minimization step. Two stacking interactions are
observed, one between W1a and D: A18 and the other between W1b and E: A18. Two possible stacking interactions are found between W3b and C:
A19 and between Y4a and C: T18. (D) Model after the second minimization step. The stacking interactions between W1a and D: A18 and between W1b
and E: A18 remain, but the two possible stacking interactions observed in part C are lost. After minimization, C: A19 is rotated away from W3b and Y4a
moved farther from C: T18. (E) Space-ﬁlling model of (WRWYCR)2 and HJ DNA after the ﬁnal minimization step, rotated  458 clockwise with respect
to panel D. The stacking interactions between W1a and D: A18 and between W1b and E: A18 are still present. The C: A19 base moved into its original
position and a new stacking interaction between the W3b residue and F: T18 was created. (F) Space-ﬁlling model of (WRWYCR)2 and HJ DNA after the
ﬁnal minimization step, 1808 rotation along the Y-axis with respect to panel E. This view highlights an additional aromatic interaction between W1b and
Y4b near the junction center, leading to a continuous parallel stack between E: A18, W1b and Y4b.
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dimer had the most interactions with the HJ substrate:
four peptide–DNA aromatic stacking interactions; one
intrapeptide p-cationic interaction (R6a–Y4a); one T-
shaped aromatic–aromatic interaction (Y4a and W1a)
and four H-bonding interactions.
Peptide (WRWYCR)2interacts withthecentral bases
ofaHJ substrate
The fact that the peptide can displace RecG from a HJ
substrate as well as the results from the molecular model-
ing experiments above suggest that (WRWYCR)2 might
make more favorable interactions with the HJ than the
wedge domain of RecG. In order to test our hypothesis
and the stacking interactions predicted by our molecular
models, we used a 2-AP ﬂuorescence-based assay. The
2-AP ﬂuorescent analog is structurally similar to adenine,
allowing it to base pair with thymine with similar confor-
mation and stability (49–51). The ﬂuorescence of 2-AP is
strongly quenched by stacking interactions with neighbor-
ing bases (52,53), generally having the lowest ﬂuorescence
intensity in dsDNA and the highest intensity in single-
stranded DNA (ssDNA). Bases at the center of the HJ
have a ﬂuorescence intensity that is intermediate between
ssDNA and dsDNA because only one side of each central
base is stacked (31). 2-AP is readily incorporated into
oligonucleotides using standard solid-phase DNA synthe-
sis, and is particularly suited for studying protein–DNA
interactions because its ﬂuorescence excitation and emis-
sion maxima are well separated from those of tryptophan
and tyrosine (50,54,55).
We synthesized and assembled HJ substrates containing
2-AP at several diﬀerent positions in order to more closely
examine potential contacts between the peptide and each
arm of the junction. For comparison, we also placed 2-AP
two or three bases away from the junction center. Partially
unstacked central bases typically lead to a 1.5- to 2-fold
increase in ﬂuorescence when compared to bases that are
completely stacked, while complete unstacking leads to an
even greater increase in ﬂuorescence (31). The sequence of
the central region of the junction substrate used is shown
in Figure 4. All junction arms are 25-bp long except for
the right arm, which is 35bp. The adenines individually
replaced by 2-AP are boxed. The 2-AP residues are iden-
tiﬁed by strand number (1–4) and then by sequential loca-
tion of the AP from the 50 end of the strand.
Reactions containing each 2-AP HJ substrate were
assembled with peptide (WRWYCR)2 and ﬂuorescence
emission spectra were recorded between 365 and 375nm
after excitation at a wavelength of 315nm. The presence of
(WRWYCR)2 quenches the ﬂuorescence of HJ-4AP1 in
a concentration-dependent manner. At a 1:4 ratio of pep-
tide dimer to substrate (indicated as 0.25 on the graph;
0.05mM peptide dimer) there is little if any change
in ﬂuorescence intensity. Maximal quenching of 1.8- to
1.9-fold is observed at 4- and 8-fold excess of peptide
(0.8 and 1.6mM peptide dimer, respectively, assuming
100% dimer in the preparation) over HJ substrate
(Figure 4 and Table 2).
HJ-4AP2 shows a similar pattern of ﬂuorescence
quenching. A 1.2-fold decrease in ﬂuorescence intensity is
observed in the presence of an equimolar ratio of
(WRWYCR)2 to substrate, and ﬂuorescence intensity
decreases by 2- to 2.2-fold at a 4- and 8-fold excess of pep-
tide over substrate, respectively (Figure 4 and Table 2).
As distance of the 2-AP residue from the branch point of
the junction increases, there is a corresponding decrease
in absolute ﬂuorescence intensity in the absence of peptide,
as expected (HJ-4AP3 and HJ-4AP4). Only the ﬂuores-
cence of the HJ-4AP3 substrate is quenched signiﬁcantly
(up to 1.7-fold) by the peptide. The maximal decrease
in ﬂuorescence observed with HJ-4AP4 is 1.2-fold. This
is consistent with previous results showing that
(WRWYCR)2 interacts speciﬁcally with the accessible cen-
tral bases of the junction, but not with linear dsDNA (22).
The remaining adenines near the branch point of the
HJ were also tested for interactions with peptide
(WRWYCR)2. HJ-1AP1 and HJ-3AP1 are located at the
branch point and are both quenched signiﬁcantly by
the peptide, but the more distal base HJ-3AP2 is not
quenched even at an 8-fold excess of peptide over sub-
strate. The overall ﬂuorescence intensity of HJ-1AP1
and HJ-3AP1 is lower than the other branch point bases
(Figure 4), but is still strongly quenched in the presence of
peptide (1.8- and 2.2-fold maximum, Table 2). It is unclear
why the ﬂuorescence of these bases is less intense in the
Table 1. Summary of predicted interactions between peptide WRWYCR and DNA substrates
Substrate Peptide–DNA p–p
stacking interactions
Intra-peptide p –
cationic interactions
H-bonds
(donor – recipient)
Fork+WRWYCR W1 – X: G10
Y4 – Y: G10
Fork+(WRWYCR)2 W1a
1 – X: G10 R6a (NH2) – Y: T8 (PO4)
Y4a – Y: G10 R2b (NH2) ! X: G10 (O6)
W1b – X: A11 R2b (NH) – X: G10 (O6)
HJ+(WRWYCR)2 W1a – D: A18 R2a (NH2) – C: A17 (PO4)
W3a or Y4a
2 – C: T18 R6a – Y4a R6b (NH2) – C: A19 (ribose O)
W1b – E: A18 R6b (OH) – C: A19 (PO4)
W3b – F: T18 W1b (CO) – F: T19 (N3)
1Each individual peptide monomer is denoted by a or b.
2W3a and Y4a both appeared able to interact with C: T18, depending on the minimization round. W3a was the amino acid which interacted in the
ﬁnal model, shown in Figure 4E and F.
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could be the result of structural variations due to sequence
diﬀerences in each strand. 2-AP ﬂuorescence is eﬃciently
quenched by neighboring guanine bases (30), and has been
shown to be particularly well-stacked and solvent-
protected within certain alternating AT-sequences (56).
The position of HJ-3AP2 corresponds to one of these
alternating AT-sequences. Consistent with this, the overall
ﬂuorescence intensity of HJ-3AP2 is lower than HJ-4AP3,
which is the ‘equivalent’ base on the neighboring
junction arm. Thus, the overall ﬂuorescence intensity of
2-AP is extremely context-dependent. Stacks of adjacent
adenine residues have also been reported to transfer
excitation energy to 2-AP (57). It is conceivable that the
adjacent adenines in strand 4 could have higher ﬂuores-
cence emissions due to this transfer of energy or as a result
of a change in base stacking, solvent protection or rota-
tional ﬂexibility. The observation that comparable
quenching by peptide is still observed at each of the
four central bases despite the diﬀerence in ﬂuorescence
intensity indicates that the overall ﬂuorescence intensity
(usually interpreted as the degree of base exposure)
does not necessarily predict speciﬁc peptide-base interac-
tions. Strong quenching is observed in ﬁve of the seven
bases tested, with the greatest quenching occurring at the
branch point of the junction regardless of overall ﬂuores-
cence intensity.
We tested additional peptides in order to determine if
there is a correlation between peptide potency and
ﬂuorescence quenching of HJ substrates. Peptide
(KWWCRW)2 is nearly as potent as (WRWYCR)2 and
binds to protein-free junctions, as observed by gel
shift and footprinting assays (19,20,22; data not shown).
In contrast, peptide WKHYNY is a very weak RecG inhi-
bitor (IC50 >20–100mM), and binding to protein-free HJ
has not been detected by gel shift assays (data not shown).
We tested binding interactions by titrating each peptide in
reaction buﬀer with HJ-4AP1 and measuring the ﬂuores-
cence emission spectra (Figure 5). As expected,
(KWWCRW)2 strongly quenches 2-AP ﬂuorescence at
concentrations comparable to peptide (WRWYCR)2.
Peptide WKHYNY has little if any eﬀect on the ﬂuores-
cence of 2-AP at this position, even at a 32-fold excess of
peptide dimer.
Figure 4. Peptide (WRWYCR)2 quenches the ﬂuorescence of 2-AP at the branch point of a HJ substrate. The locations of each 2-AP in the HJ
substrate are shown with boxes, and are named ﬁrst by strand number and then by sequential location from the 50 end of the oligonucleotide.
The numbers pointing to each trace represent the ratio of (WRWYCR)2 concentration to substrate concentration. Peptide dimer concentrations used
in each reaction were 0.05mM (0.25:1 peptide to substrate ratio), 0.2mM (1:1 peptide to substrate ratio), 0.8mM (4:1 peptide to substrate ratio) and
1.6mM (8:1 peptide to substrate ratio). Fcorr is the corrected ﬂuorescence intensity (arbitrary units) obtained by subtracting the emission spectrum of
a junction containing adenine at the position of 2-AP from the emission spectra of an equivalent reaction containing 2-AP.
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tion forksubstrates
We next investigated possible interactions between
(WRWYCR)2 and replication fork structures. Three-way
DNA junctions can be approximated as a Y-shaped
extended structure that does not undergo helix–helix
stacking in the presence of metal ions (58). The central
region of the Y-junction used in the study by Duckett
and Lilley is reactive to osmium tetroxide, indicating sol-
vent accessibility. Thus, three-way structures such as the
replication fork could be targets of the peptides. Inhibition
of RecG unwinding of replication fork structures suggests
that there is at least a transient interaction between
(WRWYCR)2 and replication forks (22). To test this, we
synthesized oligonucleotides with 2-AP placed at diﬀerent
locations and annealed the strands to form a replication
fork. The sequence of the central region of the fork sub-
strate and the positions of the 2-AP are shown in
Supplementary Figure 3.
Emission spectra were measured for each substrate
under the same conditions as the HJ (summarized
in Table 2 and shown in Supplementary Figure 3).
Fork-4AP1 shows little if any change in ﬂuorescence at
0.2mM (equimolar ratio of peptide dimer to substrate).
However, 1.5-fold quenching is observed at 0.8mM pep-
tide (4-fold excess of peptide dimer) and 1.7-fold quench-
ing is observed at 1.6mM peptide dimer (8-fold excess).
Results for Fork-4AP2 are similar and also show a con-
centration-dependent decrease in ﬂuorescence intensity
up to 2.0-fold. The ﬂuorescence of Fork-4AP3 is less
intense than that of the two previous positions, and as
seen with the HJ substrate, Fork-4AP4 is only quenched
a maximum of 1.2-fold at 1.6mM peptide. There is a
1.5-fold decrease in ﬂuorescence intensity at 370nm with
Fork-1AP1at the highest concentration of peptide tested,
while quenching of Fork-3AP2 is relatively weak (1.2-fold
maximum). In summary, relatively strong (1.5- to 2-fold)
quenching is observed at bases near the center of the repli-
cation fork substrate. As in the HJ substrate, bases away
Table 2. Summary of ﬂuorescence data
Peptide:substrate
ratio
a (peptide dimer)
0.25
(0.05mM)
1
(0.2mM)
4
(0.8mM)
8
(1.6mM)
HJ 4AP1
 b 1.0 1.2 1.9 1.8
HJ 4AP2
  1.0 1.2 2.0 2.2
HJ 4AP3 1.0 1.2 1.5 1.7
HJ 4AP4 1.0 1.0 1.2 1.2
HJ 1AP1
  1.1 1.2 1.6 1.8
HJ 3AP1
  1.1 1.3 2.0 2.2
HJ 3AP2 0.9 1.0 1.1 1.1
Fork 4AP1
  1.0 1.1 1.5 1.7
Fork 4AP2
  1.0 1.0 1.4 2.0
Fork 4AP3 1.0 1.0 1.2 1.5
Fork 4AP4 1.0 1.0 1.0 1.2
Fork 1AP1
  1.0 1.0 1.2 1.5
Fork 3AP2 0.9 1.0 1.1 1.2
Lag 4AP1
  1.0 1.1 1.3 1.9
Lag 4AP2
  1.0 1.1 1.3 1.6
Lag 4AP3 1.0 1.0 1.2 1.3
Lag 4AP4 1.0 1.0 1.1 1.0
Lag 1AP1
  1.0 1.0 1.3 2.0
Lag 3AP2 1.0 1.0 1.1 1.1
Lead 4AP1
  1.0 1.1 1.3 1.7
Lead 4AP2
  1.0 1.1 1.2 1.5
Lead 4AP3 1.0 1.1 1.2 1.5
Lead 4AP4 1.1 1.0 1.1 1.2
Lead 1AP1
  1.0 1.1 1.1 1.3
Flayed 4AP1
  1.1 1.1 1.2 1.5
Flayed 4AP2
  1.0 1.1 1.3 1.4
Flayed 4AP3 1.0 1.1 1.2 1.3
Flayed 4AP4 1.0 1.0 1.1 1.2
Flayed 1AP1
  1.1 1.1 1.1 1.3
Values represent the fold decrease in 2-AP ﬂuorescence at 370nm in the
presence of the indicated amounts of peptide relative to the absence of
peptide.
aThe ratio of peptide dimer concentration to substrate concentration
is given, with the actual concentration of peptide dimer shown in par-
entheses. The concentration of DNA substrate in each reaction was
0.2mM.
b2-AP residues at the center of the DNA substrate are marked with an
asterisk.
Figure 5. Peptide (KWWCRW)2 interacts with 4AP1 in the HJ sub-
strate, but WKHYNY does not interact. Peptide (KWWCRW)2 (A)o r
peptide WKHYNY (B) was titrated in reactions containing 0.2mM
substrate, 20mM Tris–HCl (pH 7.8), 100mM NaCl, 1mM EDTA,
and 1.6% DMSO. Peptide concentrations were 0.05mM (0.25:1 peptide
to substrate ratio), 0.2mM (1:1 peptide to substrate ratio), 0.8mM
(4:1 peptide to substrate ratio), 3.2mM (16:1 peptide to substrate
ratio) and 6.4mM (32:1 peptide to substrate ratio). The concentration
of WKHYNY is also expressed as a dimer for consistency.
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by the peptide.
The results thus far indicate that (WRWYCR)2 binds
to DNA substrates that resemble replication forks.
Previously, we observed that this peptide inhibits RecG
most on a fork substrate with only the lagging strand
and least on a fork substrate with only the leading
strand (22). This could be explained if (WRWYCR)2 has
diﬀerent aﬃnities for distinct substrates. We again tested
peptide binding using fork substrates with individual
adenines replaced by 2-AP, but only assembled annealing
reactions with the ‘lagging strand’ oligonucleotide
(Table 2 and Supplementary Figure 4). Similarly to the
replication fork with three double-stranded arms, the
fork containing only the lagging strand (Lag-4AP1) and
lagging strand fork 4AP2 (Lag-4AP2) are quenched
strongly by the peptide (Table 2 and Supplementary
Figure 4). In contrast, Lag-4AP3 and Lag-4AP4 are
quenched relatively weakly.
The single-stranded Lag-1AP1 is greatly ﬂuorescent
(up to >5-fold) in comparison to the other 2-AP positions
(Supplementary Figure 4). An increase in base exposure to
solvent at this position is expected to favor peptide bind-
ing. Indeed, ﬂuorescence is quenched at a 4- and 8-fold
molar excess of (WRWYCR)2 over substrate (Table 2).
To ensure that peptide binding is the result of local repli-
cation fork structure, we titrated (WRWYCR)2 in a bind-
ing reaction with the 1AP1 oligonucleotide alone (data not
shown). Unlike the lagging strand fork substrate, there is
no signiﬁcant quenching at an 8-fold molar excess of pep-
tide. Quenching begins at a 16-fold peptide excess and
increases at 32-fold excess of peptide, indicating that the
peptide binds to ssDNA at very high concentrations
(nevertheless, the magnitude of quenching on the oligo is
not as great as the magnitude of quenching on the lagging
strand fork). This result is not surprising since peptide
(WRWYCR)2 binds to dsDNA nonspeciﬁcally at high
concentrations (20). The ﬁnal 2-AP position tested in
this substrate, Lag-3AP2, showed only very weak quench-
ing by peptide.
We also tested, the fork substrate with only the leading
strand for ﬂuorescence quenching by (WRWYCR)2
(Table 2). Lead-4AP1, Lead-4AP2 and Lead4AP3 are all
quenched by the peptide, but Lead-4AP4 and Lead-1AP1
are less sensitive: the double-stranded Lead-1AP1 shows
only a 1.3-fold decrease in ﬂuorescence intensity at 1.6mM
peptide. This is in contrast to the strong quenching
observed in the lagging strand fork substrate at this posi-
tion, and supports the idea that a more exposed base at
this position favors peptide binding. The ﬁnal substrate
tested did not contain either the lagging or leading strands,
but comprised a ‘ﬂayed’ duplex molecule (Table 2).
Flayed-4AP1, Flayed-4AP2 and Flayed-4AP3 are even
less sensitive to quenching by (WRWYCR)2 than the lead-
ing strand fork substrate. Flayed-4AP4 and Flayed-1AP1
are again only weakly quenched by peptide. Thus, our
results indicate that peptide binding largely depends on
at least two double-stranded arms (a template arm and
in particular a lagging strand arm) in the replication
fork for stability.
Peptide (WRWYCR)2binds tobranched DNA
substrateswith differentaffinities
In general, (WRWYCR)2 quenches 2-AP ﬂuorescence
most strongly in HJ, is weaker in quenching 2-AP ﬂuores-
cence in the leading strand fork, and weakest on ﬂayed
duplex substrates (Table 2). The 2-AP in the complete fork
substrate and the lagging strand fork are quenched at
intermediate concentrations of peptide. More extensive
titrations of peptide were performed with each substrate
to verify this observation; the 2-AP was at the 4AP2 posi-
tion in each substrate. Reactions were assembled in buﬀer
containing 0.1mM substrate and peptide was subsequently
added resulting in 2-fold step increases in concentra-
tion. The fraction of peptide/substrate complex formed
(Fc, Figure 6 legend) was determined and plotted for com-
parison (the actual points). As expected, the results indi-
cate that there is indeed a diﬀerence in binding aﬃnity
between each substrate (Figure 6).
In order to obtain an equilibrium Kd value of peptide
for each substrate, the data were ﬁt to the binding equa-
tion shown in Materials and methods section using a non-
linear least squares ﬁtting algorithm. The ﬁtting was
accomplished by adjusting the dissociation constant Kd
to values of the total peptide added, Lt, and spectro-
scopically measured values of the fraction of substrate
complexed with peptide, Fc. The calculated Kd with
Figure 6. Peptide (WRWYCR)2 interacts with branched DNA struc-
tures with diﬀerent aﬃnities. The aminopurine was located in strand 4,
position 2 (4AP2) in each substrate. Peptide additions were made
resulting in 2-fold concentration increases at each interval, starting
with 0.003125mM. After incubation for 3min, emission spectra were
recorded between 330 and 430nm at 1nm intervals using an excitation
wavelength of 315nm. Corrected ﬂuorescence intensity (Fcorr) values
were calculated by subtracting 2-AP emission spectra by the spectra
from equivalent titrations with the 2-AP nucleotide replaced with ade-
nine. The Fcorr values for each peptide concentration were averaged
from a window of 365–375nm and used to calculate Fc, the fraction
of peptide/substrate complex formed. Fc is deﬁned as (FP–F0)/(FS–F0),
where FP is the average corrected ﬂuorescence intensity in the pre-
sence of peptide dimer concentration P, F0 is the average corrected
ﬂuorescence intensity without peptide and FS is the average corrected
ﬂuorescence intensity at saturation. Fc was plotted as a function of
(WRWYCR)2 concentration. The inset graph shows the binding
curves over almost the entire range of concentrations tested.
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2 values are shown in Table 3. The best
ﬁts (Figure 6) indicated that peptide (WRWYCR)2 binds
with the highest aﬃnity to HJ (Kd of 14.3nM). The sub-
strates can be divided into three groups according to
strength of binding, with the strongest binding for HJ,
medium strength binding for Lead, Lag and Fork, and
weak binding for ﬂayed and oligo.
As described above, binding to all of the substrates
is measured by the quenching of a ﬂuorescent base,
2-AP, at one position in each DNA molecule and thus
the null hypothesis is that 2-AP reports a single binding
site for the peptide dimer. An alternate hypothesis, how-
ever, is that binding of additional peptides elsewhere on
the substrate can aﬀect the interactions of the peptide
bound at the center of the junction, where the 2-AP base
is located. This alternative n>1 hypothesis is explored
further in the Supplement; however, the qualitative picture
implied by the two hypotheses is the same. We conclude
that there is very good correlation between inhibition
of RecG activity and substrate binding aﬃnity of
(WRWYCR)2 to replication forks and HJ substrates.
Therefore, the inhibition of RecG activity on replication
forks is most simply explained by competition between
RecG and (WRWYCR)2 for these substrates.
(WRWYCR)2bindingto branched DNA is sensitive toDTT
As mentioned above, previous results indicated that the
active conformation of peptide (WRWYCR)2 for inhibi-
tion of Int-mediated recombination is a dimer linked
through a disulﬁde bridge (20). Gel shift assays showed
that peptides bind to protein-free HJ as dimers (22).
The crystal structure of peptide WKHYNY bound to
the Cre/HJ complex strongly implies that even this rela-
tively weak peptide binds as a dimer (23), although it
requires Cre to make the HJ into a target. However, the
stoichiometry of WRWYCR with respect to fork struc-
tures is less clear. Based on the fact that forks roughly
resemble half a HJ the peptide may, in principle, bind to
forks as a monomer. However, the molecular modeling
studies predict more interactions between a fork and a
peptide dimer than a monomer. We tested this question
directly by assembling reactions with each substrate in the
presence and absence of DTT (Figure 7). A relatively high
concentration of peptide dimer (1.6mM or an 8-fold
excess) was used for each experiment to provide suﬃcient
ﬂuorescence quenching. The 2-AP at position 4AP2 was
used for each substrate. The presence of 10mM DTT
signiﬁcantly decreases ﬂuorescence quenching of the HJ
substrate by the peptide (Figure 7A). The extent of the
reduced quenching for each substrate is summarized in
Figure 7B. Depending on the substrate, the peptide
quenches ﬂuorescence of 4AP2 by 1.7- to 2.6-fold in the
absence of DTT, but only by 1.2- to 1.3-fold in the pre-
sence of DTT. Thus, the most active form of peptide
(WRWYCR)2 is a dimer even when targeting replication
fork DNA substrates.
DISCUSSION
Peptides (WRWYCR)2 and (KWWCRW)2 block site-
speciﬁc recombination mediated by tyrosine recombinases
by binding to the HJ intermediate of this family of reac-
tions and inhibiting further catalysis. These peptides
recognize protein-free HJ and inhibit resolution by several
HJ resolvases. The RecG branched-DNA-speciﬁc helicase
and the RuvABC complex are inhibited about as well as
are Cre and XerC/D, with an IC50 of  50nM, 500–1000X
more eﬀective inhibition than of RuvC alone, T7 endonu-
clease I or RusA (22). Based on biochemical data includ-
ing KMnO4 footprinting experiments, we proposed that
the peptides inhibit most eﬃciently processing of those
junctions that are in the most open conﬁguration for the
Table 3. Summary of calculated Kd values for DNA substrates
Substrate Kd (nM) R
2 Fold reduced
versus HJ
a
Holliday junction 14.3 3.2 0.992 1
Complete fork 63.5 12.0 0.958 4.4
Lagging strand fork 79.2 17.3 0.942 5.5
Leading strand fork 132 32.8 0.963 9.2
Flayed fork 628 107 0.913 43.9
Oligo 731 134 0.923 51.1
aComparison of Kd values (aﬃnities) of the peptide for the HJ with the
Kd values for other substrates.
Figure 7. Fluorescence quenching of (WRWYCR)2 is sensitive to DTT.
Reactions were as described for Figure 4. Spectra were recorded in the
presence or absence of 10mM DTT and 1.6mM peptide dimer (8-fold
excess dimer: substrate). Fcorr values were calculated as above. The
2-AP in strand 4, position 2 (4AP2) was used for each substrate.
(A) Spectra obtained for the HJ substrate in the presence and absence
of DTT and peptide, plotted on the same graph. (B) Summary of the
fold-decrease in ﬂuorescence intensity at 370nm in presence and
absence of DTT for the HJ and each remaining substrate.
5330 Nucleic Acids Research, 2008, Vol. 36, No. 16longest time. Thus, inhibition of junction resolution by
RuvABC is more eﬀective than inhibition of RuvC
alone because the junction substrate is in the square
planar conformation longer when the RuvABC complex
is bound. In agreement with our hypothesis, the crystal
structure of T7 endonuclease I—DNA complex shows
that, while the central bases of the junction are unstacked,
there is relatively little free space in the junction center
when the enzyme is bound (59). To understand the mole-
cular basis of inihibition by these peptide in detail, struc-
tural information on peptide-junction interactions would
clearly be very useful.
In addition to needing a framework for the mechanism
of DNA binding by the peptides, inhibition of RecG by
(WRWYCR)2 presented a dilemma: inhibition of RecG
activity occurred both on HJ and on replication fork sub-
strates (complete or partial), but we were only able to
demonstrate peptide binding to the HJ when we used gel
shift assays (22). Inhibition of RecG by (WRWYCR)2
should depend on both the relative aﬃnity of RecG and
peptide for the HJ substrate and their relative rates of
dissociation. Our latest data indicate that although
RecG and (WRWYCR)2 have similar binding aﬃnities
for junctions when using our gel shift assay conditions,
the RecG/HJ complex dissociates  2X faster and the pep-
tide can displace RecG from the HJ substrate. Thus, the
peptide forms more stable complexes with junctions than
RecG. The 2-AP ﬂuorescence-based solution assay results
show that peptides WRWYCR and KWWCRW bind to
replication fork-like substrates. In aggregate, these results
demonstrate that the peptides inhibit RecG activity on
replication fork substrates and HJ by direct competition
between RecG and peptide for the branched DNAs.
Competitive inhibition between RecG and peptide sup-
ports the idea that stacking interactions between each
peptide and DNA may resemble those observed between
the wedge domain of RecG and replication fork DNA.
The structural model proposed in Figure 3 shows that
stacking interactions between the peptide and several of
the central bases in a HJ substrate can occur, and the 2-AP
ﬂuorescence results conﬁrm such stacking interactions.
Bases at the branch point of each substrate were more
sensitive to quenching by the peptide than bases located
2–3 bases away from the center, suggesting that for pep-
tide WRWYCR and KWWCRW intercalation between
nucleotides further from the center of the junction
almost certainly does not occur beyond at most two
nucleotide steps. The modeling provides a theoretical
explanation for the more stable and higher aﬃnity inter-
actions of the peptide with HJ versus fork substrates and
why a peptide dimer shows more stable interactions with
the HJ than a monomer. The interactions between sub-
strate and peptide increase as the substrate changes from
a fork to a junction, and as the peptide is dimerized
(Table 1). In the peptide–HJ model, the peptide makes
4p–p aromatic stacking interactions between amino acids
in the peptide and central bases in the HJ. One of the
amino acid-base stacking interactions may be further sta-
bilized by a p–p aromatic stacking interactions between
two amino acids (45) to form a 3-member stack between
the base E: A18 and amino acids W1b and Y4b of one of
the peptide monomers. Across the junction center, the
stacking interaction between the base D: A18 and W1a
may be further stabilized by an aromatic–aromatic
T-shaped (orthogonal) interaction between Y4a and
W1a (Figure 3D and 3E; 45,46). Finally, the folded pep-
tide structure in the model may also be stabilized by a
p-cationic intra-peptide interaction (47,48) between R6a
and Y4a.
With respect to matching the 2-AP ﬂuorescence data
with the structural models, the ﬂuorescence quenching
data presented here is limited to half of the central
bases. While the position of each peptide-base stacking
interaction does not exactly match the position of the
2-AP ﬂuorescence quenching, the results are quite similar.
Four 2-AP bases at the immediate center of the HJ are
quenched at least 1.6-fold at a 4-fold excess of peptide
dimer over substrate (Table 2). Two of the four peptide–
base stacking interactions in the (WRWYCR)2/HJ model
(Figure 3E and F) agree with the 2-AP ﬂuorescence
quenching results, while the remaining two interactions
occur at the complementary bases. A complete but prelim-
inary set of 2-AP quenching assays tested all of the central
bases of the HJ by changing the sequence of the relevant
oligos and thus the location of the 2-AP residue (Boldt,J.
and Segall,A., unpublished data). In these assays, seven
of the eight central bases were very strongly quenched
by the peptide (>2X), and the eighth base was moderately
quenched (1.6X). In contrast, the structural models sug-
gest that the peptide would only quench one of the two
bases in a given base pair. Perhaps peptide binding is
suﬃciently ﬂexible that stacking interactions may occur
with diﬀerent bases depending on the actual sequence at
the branch center. This possibility would help account for
the poor resolution of the peptide in the Cre-loxPHJ-
peptide crystal, and will be tested in the future. Eﬀorts
are underway to obtain structures of (WRWYCR)2
bound to a protein-free HJ.
In addition to showing that peptides bind to replication
forks and providing substantial validation for the struc-
tural models, the 2-AP studies provided an independent,
solution-based assay for determining the aﬃnity of the
peptides to several diﬀerent DNA substrates, including
replication fork-like substrates. The isolated wedge
domain of RecG does not bind replication forks (at least
stably enough for gel-based detection), requiring an addi-
tional motif consisting of three conserved residues (CVG)
that interact with the lagging strand arm (12,27). The
extra contacts a peptide dimer is able to make compared
to a peptide monomer may substitute for the interactions
made by RecG’s CVG motif. RecG has a 10- to 100-fold
weaker aﬃnity for ﬂayed duplex DNA molecules when
compared to HJ (11,17). (WRWYCR)2 binds with the
highest aﬃnity to HJ, about 4–5X less to complete and
lagging strand replication forks, and about 9X less to
leading strand forks. It remains to be seen whether the
stoichiometry of the peptide dimer is also one for the
replication fork-like substrates. Binding to the ﬂayed
DNA substrate, which has the most single-stranded char-
acter, is much weaker ( 44X reduced) and is likely to
include nonspeciﬁcally bound peptides.
Nucleic Acids Research, 2008, Vol. 36, No. 16 5331Not all small aromatic peptides quench the 2-AP ﬂuo-
rescence in the center of HJ: WKHYNY shows almost no
quenching (Figure 6B), despite a concentration-dependent
quenching eﬀect on 2-AP when interacting with the
Cre/HJ complex (23). The Cre-protein (and the Int protein
by analogy; 21) must contribute to stabilizing interactions,
most likely by opening the center of the HJ and providing
a more conducive environment to peptide binding. The
weaker binding of WKHYNY may be due to its being
a monomer in solution until complexed with Cre/HJ
complexes (23).
KMnO4 footprinting assays showed that central thy-
mine bases (up to two bases from the center) are more
sensitive to modiﬁcation in the presence of peptide or
RecG, which increases KMnO4 sensitivity nearly 2-fold
when bound to HJ (22). These bases presumably become
more exposed to solution when bound either by RecG or
by peptide. Hence, it might be reasonable to predict that
2-AP ﬂuorescence should also increase in the presence of
peptide, as has been observed with the HJ resolvases
CCE1 of S. cerevisiae and T7 endonuclease I (31,32).
These proteins function by distorting the global conforma-
tion of the junction, triggering a conformational change in
the DNA that activates catalysis (60) without concomi-
tantly making direct stacking contacts with the central
bases (59). The extensive disruption caused by T7 endo-
nuclease I is due to interactions between the protein and
the junction arms (59), leading both to an overall increase
in KMnO4 sensitivity and a very large increase in 2-AP
ﬂuorescence (31). In contrast, the increase in KMnO4
modiﬁcation accompanied by quenching of 2-AP ﬂuores-
cence by (WRWYCR)2 argues in favor of a model in
which direct stacking of aromatic amino acids in the pep-
tide promotes a modest rotation or opening of central
bases and at the same time provides access for attack by
the small permanganate ions during footprinting. The
structural model shown in Figure 3 certainly allows for
the accessibility of KMnO4. This mechanism of peptide
binding would directly interfere with critical interactions
between junction-processing enzymes and the central
region of the HJ.
In summary, the ﬂuorescent probe 2-AP permits detec-
tion of speciﬁc interactions between peptide inhibitors and
branched DNA substrates, and is a more sensitive assay
than gel electrophoresis. Dimerization is essential for all
DNA binding, especially to HJ and replication fork sub-
strates. The very good correlation between inhibition of
RecG activity (22) and substrate binding aﬃnity of
(WRWYCR)2 to replication forks and HJ substrates
together with the competition data show that the inhibi-
tion of RecG activity is most simply explained by compe-
tition between the helicase and the peptides for the same
substrates. In addition to the prediction that any junction
resolvase or branch migrase which interacts with the open
form of a branched DNA is expected to be a good target
of peptide inhibition, the converse—that enzymes which
are poorly inhibited by the peptides are likely to work on
substrates in more stacked conformations—is also likely
to be true, and should be a useful simple test in the char-
acterization of these enzyme families.
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